This site is intended for U.S. audiences only.

IDHIFA® is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children.

Tools & Resources

IDHIFA® WALLET CARDS

- This printable resource provides information about differentiation syndrome and other potential side effects of IDHIFA®

- It also includes cards for you and your caregiver to cut out and keep in your wallets

- If you visit the emergency room or a doctor who is not on your regular healthcare team, show this card so they will know you are being treated with IDHIFA®

Download Descargar en español

DOCTOR DISCUSSION GUIDE

Download

Caregiver Brochure

Download

Full Prescribing Information

Download

Medication Guide

Download

IDHIFA® Pricing Information

Learn More